Gene · 4821
Papers1,860
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,860
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Understanding cell fate acquisition in stem-cell-derived pancreatic islets using single-cell multiome-inferred regulomes. | Dev Cell | 2023 | 37040771 | PubTator, text mining | PubMed |
| Monogenic diabetes in New Zealand - An audit based revision of the monogenic diabetes genetic testing pathway in New Zealand. | Front Endocrinol (Lausanne) | 2023 | 37033247 | PubTator, text mining | PubMed |
| CD43-positive, EWSR1::FLI1 -rearranged Soft Tissue Sarcoma in a Pediatric Patient With History of B-Cell Acute Lymphoblastic Leukemia. | J Pediatr Hematol Oncol | 2023 | 37027334 | PubTator, text mining | PubMed |
| Ewing's Sarcoma of the Zygoma: A Very Rare Location. | Cureus | 2023 | 37025747 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation profiling after Ayurveda intervention to bronchial asthmatics identifies differential methylation in several transcription factors with immune process related function. | J Ayurveda Integr Med | 2023 | 37018893 | PubTator, text mining | PubMed |
| Highly connected 3D chromatin networks established by an oncogenic fusion protein shape tumor cell identity. | Sci Adv | 2023 | 37000878 | PubTator, text mining | PubMed |
| CD99 and NKX2.2 positive neuroblastoma diagnosed on cytology: A potential diagnostic pitfall and necessity of pathological evaluation of the primary site. | Diagn Cytopathol | 2023 | 36999306 | PubTator, text mining | PubMed |
| The Recent Advances in Molecular Diagnosis of Soft Tissue Tumors. | Int J Mol Sci | 2023 | 36983010 | PubTator, text mining | PubMed |
| Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application. | Int J Mol Sci | 2023 | 36982236 | PubTator, text mining | PubMed |
| Management of Recurrent Retroperitoneal Sarcoma. | Curr Oncol | 2023 | 36975422 | PubTator, text mining | PubMed |
| Bulk and single-cell transcriptome analyses of islet tissue unravel gene signatures associated with pyroptosis and immune infiltration in type 2 diabetes. | Front Endocrinol (Lausanne) | 2023 | 36967805 | PubTator, text mining | PubMed |
| Direct reprogramming of human fibroblasts into insulin-producing cells using transcription factors. | Commun Biol | 2023 | 36964318 | PubTator, text mining | PubMed |
| Generation of functional posterior spinal motor neurons from hPSCs-derived human spinal cord neural progenitor cells. | Cell Regen | 2023 | 36949352 | PubTator, text mining | PubMed |
| Top 10 Histological Mimics of Neuroendocrine Carcinoma You Should Not Miss in the Head and Neck. | Head Neck Pathol | 2023 | 36941503 | PubTator, text mining | PubMed |
| Shared genetics and bidirectional causal relationships between type 2 diabetes and attention-deficit/hyperactivity disorder. | Gen Psychiatr | 2023 | 36937092 | PubTator, text mining | PubMed |
| Sinonasal NUT carcinoma: A retrospective case series from a single institution. | Front Surg | 2023 | 36936659 | PubTator, text mining | PubMed |
| Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer. | Br J Cancer | 2023 | 36932191 | PubTator, text mining | PubMed |
| Rare Case of BCOR::CCNB3 Sarcoma of Bone. | Am J Case Rep | 2023 | 36915189 | PubTator, text mining | PubMed |
| Genetic testing can change diagnosis and treatment in children with congenital hypothyroidism. | Eur Thyroid J | 2023 | 36913313 | PubTator, text mining | PubMed |
| Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data. | Radiat Oncol | 2023 | 36906590 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4821/papers?page=15